FDA Inspection
BSP Pharmaceuticals SpABSP Pharmaceuticals SpA – FDA Inspection, Jun 26, 2015
Record Details
This FDA Inspection record concerns BSP Pharmaceuticals SpA, with an inspection on June 26, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BSP Pharmaceuticals SpA
- Inspection Date
- June 26, 2015
- Product Type
- Drugs
View Company Profile
ID · 14269f8f-2bbb-49d1-baef-69ba82aa95d2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 935609
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(a)Following/documenting laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BSP Pharmaceuticals SpA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 29, 2024 | Not classified | Office of Inspections and Investigations | |
| November 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | Not classified | Office of Inspections and Investigations | |
| October 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSP Pharmaceuticals SpA
- FDA Inspection 1232171 - 2024-02-29
- FDA Inspection 1172555 - 2021-11-12
- FDA Inspection 1071722 - 2018-09-21
- FDA Inspection 1091112 - 2017-10-20
- FDA Inspection 1016102 - 2016-12-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.